FDA Approval Makes Rocket Pharma Gene Therapy the First for Ultra-Rare Immune DisorderNews DeskMarch 29, 20260 A Rocket Pharmaceuticals gene therapy has landed a long-awaited FDA approval, bringing a new treatment option to patients with a…
FDA Approval for Denali Therapeutics Blazes a New Trail for Brain-Penetrating DrugsNews DeskMarch 26, 20260 Hunter syndrome patients can manage the disorder with a drug that addresses disease symptoms throughout the body except the brain…
AI Won’t Replace Clinical Trial Teams, But It Fixes the Bottlenecks That Keep Patients OutNews DeskMarch 24, 20260 Clinical trials don’t fail because patients aren’t willing to participate. They fail because we never find most of the people…